T1	Participants 48 66	oncologic patients
T2	Participants 252 267	cancer patients
T3	Participants 778 861	240 patients with diagnosed malignancy and pain > 3 days and average pain >or= 3/10
T4	Participants 1878 1936	patients continue to be used after discharge from hospital
